This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Argyll Biotechnologies, LLC., Other. Active years: 2004-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2008
Title: Innovations and Contributions of Kenneth O Willeford
Introduction
Kenneth O Willeford is a notable inventor based in Starkville, MS (US). He has made significant contributions to the field of immunology through his innovative research and patents. With a total of two patents to his name, Willeford's work focuses on immune stimulation and therapeutic applications.
Latest Patents
Willeford's latest patents include "Prophylactic and therapeutic benefits of a new class of immune stimulating peptides" and "Composition and method for immunostimulation in non-mammalian vertebrates." The first patent describes a new class of lipopeptides discovered from mammalian serum, which are potent immunoregulators known as Immune Cell Potentiating Factors (ICPFs). Clinical and laboratory data indicate a wide range of applications for these ICPFs, including treatment for diseases of bacterial and viral origin, as well as certain neoplastic diseases. The second patent relates to compositions that modulate the immune system of non-mammalian vertebrates, utilizing low molecular weight immunoglobulin-free fractions isolated from mammals to induce an immune response.
Career Highlights
Throughout his career, Willeford has worked with various companies, including Argyll Biotechnologies, LLC. His research has led to advancements in immunotherapy and has opened new avenues for treating various diseases.
Collaborations
Willeford has collaborated with notable individuals in his field, including Daniel R Ansley and James D Thacker. These collaborations have contributed to the development and refinement of his innovative ideas.
Conclusion
Kenneth O Willeford's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence therapeutic strategies and improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile